INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• The Industry’s First And Only Unified Platform For RWE Generation

  Built on interoperability, intelligence, and regulatory rigor, Castor Catalyst provides the infrastructure to connect, the automation to scale, and the expertise to turn complex data into actionable evidence.

• eCOA In Oncology Trials: A Tool To Simplify

  Accurate quality of life data is critical in oncology. eCOA unified with IRT streamlines trials, improves data collection, and enhances site user experiences across therapeutic areas.

• Hidden Costs Of Data Cleaning: Build Quality At The Source

  Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.

• A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity

  The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.

• Is Your Legacy EDC Limiting AI's Impact On Your Clinical Data?

  1/26/2026

  AI can enhance clinical data workflows, but aging EDC systems hold teams back. This piece breaks down key barriers and shows what’s needed to modernize data foundations for meaningful AI adoption.

• Remote Patient Monitoring Using Mobile Health Technology

  3/28/2025

  This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment.

• 2025 Big Ideas In Clinical Trials: A Conversation

  7/30/2025

  Clinical trials are being redefined by three key forces: true patient-centricity, a rising focus on corporate responsibility and sustainability, and the push for greater efficiency through innovative designs.

• Do CROs Need To Reinvent Themselves In 2025?

  3/21/2025

  Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

• The Silent Saboteurs: Why Rater Drift And Site Unpreparedness Cost CNS Trials More

  3/25/2026

  High-end technology cannot fix poor rater preparation or complex patient needs. True data integrity requires bridging the gap between digital platforms and the reality of clinical implementation.